866-997-4948(US-Canada Toll Free)

Europe Recombinant Human Insulin Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Insulin

No. of Pages : 127 Pages

Notes:
Sales, means the sales volume of Recombinant Human Insulin
Revenue, means the sales value of Recombinant Human Insulin

This report studies sales (consumption) of Recombinant Human Insulin in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Novo Nordisk
Eli Lilly
Bioton
Dongbao
United Laboratories (TUL)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Recombinant Human Insulin in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by application, this report focuses on sales, market share and growth rate of Recombinant Human Insulin in each application, can be divided into
Application 1
Application 2

Table of Contents

Europe Recombinant Human Insulin Market Report 2017
1 Recombinant Human Insulin Overview
1.1 Product Overview and Scope of Recombinant Human Insulin
1.2 Classification of Recombinant Human Insulin
1.2.1 Type I
1.2.2 Type II
1.3 Application of Recombinant Human Insulin
1.3.1 Application 1
1.3.2 Application 2
1.4 Recombinant Human Insulin Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Recombinant Human Insulin (2012-2022)
1.5.1 Europe Recombinant Human Insulin Sales and Growth Rate (2012-2022)
1.5.2 Europe Recombinant Human Insulin Revenue and Growth Rate (2012-2022)

2 Europe Recombinant Human Insulin by Manufacturers, Type and Application
2.1 Europe Recombinant Human Insulin Market Competition by Manufacturers
2.1.1 Europe Recombinant Human Insulin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Recombinant Human Insulin Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Recombinant Human Insulin (Volume and Value) by Type
2.2.1 Europe Recombinant Human Insulin Sales and Market Share by Type (2012-2017)
2.2.2 Europe Recombinant Human Insulin Revenue and Market Share by Type (2012-2017)
2.3 Europe Recombinant Human Insulin (Volume and Value) by Countries
2.3.1 Europe Recombinant Human Insulin Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Recombinant Human Insulin Revenue and Market Share by Countries (2012-2017)
2.4 Europe Recombinant Human Insulin (Volume) by Application

3 Germany Recombinant Human Insulin (Volume, Value and Sales Price)
3.1 Germany Recombinant Human Insulin Sales and Value (2012-2017)
3.1.1 Germany Recombinant Human Insulin Sales and Growth Rate (2012-2017)
3.1.2 Germany Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
3.1.3 Germany Recombinant Human Insulin Sales Price Trend (2012-2017)
3.2 Germany Recombinant Human Insulin Sales and Market Share by Manufacturers
3.3 Germany Recombinant Human Insulin Sales and Market Share by Type
3.4 Germany Recombinant Human Insulin Sales and Market Share by Application

4 France Recombinant Human Insulin (Volume, Value and Sales Price)
4.1 France Recombinant Human Insulin Sales and Value (2012-2017)
4.1.1 France Recombinant Human Insulin Sales and Growth Rate (2012-2017)
4.1.2 France Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
4.1.4 France Recombinant Human Insulin Sales Price Trend (2012-2017)
4.2 France Recombinant Human Insulin Sales and Market Share by Manufacturers
4.3 France Recombinant Human Insulin Sales and Market Share by Type
4.4 France Recombinant Human Insulin Sales and Market Share by Application

5 UK Recombinant Human Insulin (Volume, Value and Sales Price)
5.1 UK Recombinant Human Insulin Sales and Value (2012-2017)
5.1.1 UK Recombinant Human Insulin Sales and Growth Rate (2012-2017)
5.1.2 UK Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
5.1.5 UK Recombinant Human Insulin Sales Price Trend (2012-2017)
5.2 UK Recombinant Human Insulin Sales and Market Share by Manufacturers
5.3 UK Recombinant Human Insulin Sales and Market Share by Type
5.4 UK Recombinant Human Insulin Sales and Market Share by Application

6 Russia Recombinant Human Insulin (Volume, Value and Sales Price)
6.1 Russia Recombinant Human Insulin Sales and Value (2012-2017)
6.1.1 Russia Recombinant Human Insulin Sales and Growth Rate (2012-2017)
6.1.2 Russia Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
6.1.6 Russia Recombinant Human Insulin Sales Price Trend (2012-2017)
6.2 Russia Recombinant Human Insulin Sales and Market Share by Manufacturers
6.3 Russia Recombinant Human Insulin Sales and Market Share by Type
6.4 Russia Recombinant Human Insulin Sales and Market Share by Application

7 Italy Recombinant Human Insulin (Volume, Value and Sales Price)
7.1 Italy Recombinant Human Insulin Sales and Value (2012-2017)
7.1.1 Italy Recombinant Human Insulin Sales and Growth Rate (2012-2017)
7.1.2 Italy Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
7.1.7 Italy Recombinant Human Insulin Sales Price Trend (2012-2017)
7.2 Italy Recombinant Human Insulin Sales and Market Share by Manufacturers
7.3 Italy Recombinant Human Insulin Sales and Market Share by Type
7.4 Italy Recombinant Human Insulin Sales and Market Share by Application

8 Spain Recombinant Human Insulin (Volume, Value and Sales Price)
8.1 Spain Recombinant Human Insulin Sales and Value (2012-2017)
8.1.1 Spain Recombinant Human Insulin Sales and Growth Rate (2012-2017)
8.1.2 Spain Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
8.1.8 Spain Recombinant Human Insulin Sales Price Trend (2012-2017)
8.2 Spain Recombinant Human Insulin Sales and Market Share by Manufacturers
8.3 Spain Recombinant Human Insulin Sales and Market Share by Type
8.4 Spain Recombinant Human Insulin Sales and Market Share by Application

9 Benelux Recombinant Human Insulin (Volume, Value and Sales Price)
9.1 Benelux Recombinant Human Insulin Sales and Value (2012-2017)
9.1.1 Benelux Recombinant Human Insulin Sales and Growth Rate (2012-2017)
9.1.2 Benelux Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Recombinant Human Insulin Sales Price Trend (2012-2017)
9.2 Benelux Recombinant Human Insulin Sales and Market Share by Manufacturers
9.3 Benelux Recombinant Human Insulin Sales and Market Share by Type
9.4 Benelux Recombinant Human Insulin Sales and Market Share by Application

10 Europe Recombinant Human Insulin Manufacturers Analysis
10.1 Novo Nordisk
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Recombinant Human Insulin Product Type, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Novo Nordisk Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Eli Lilly
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Recombinant Human Insulin Product Type, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Eli Lilly Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Bioton
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Recombinant Human Insulin Product Type, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Bioton Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Dongbao
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Recombinant Human Insulin Product Type, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Dongbao Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 United Laboratories (TUL)
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Recombinant Human Insulin Product Type, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 United Laboratories (TUL) Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview

11 Recombinant Human Insulin Manufacturing Cost Analysis
11.1 Recombinant Human Insulin Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Recombinant Human Insulin

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Recombinant Human Insulin Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Recombinant Human Insulin Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Recombinant Human Insulin Market Forecast (2017-2022)
14.1 Germany Recombinant Human Insulin Sales Forecast (2017-2022)
14.2 France Recombinant Human Insulin Sales Forecast (2017-2022)
14.3 UK Recombinant Human Insulin Sales Forecast (2017-2022)
14.4 Russia Recombinant Human Insulin Sales Forecast (2017-2022)
14.5 Italy Recombinant Human Insulin Sales Forecast (2017-2022)
14.6 Spain Recombinant Human Insulin Sales Forecast (2017-2022)
14.7 Benelux Recombinant Human Insulin Sales Forecast (2017-2022)
14.8 Europe Recombinant Human Insulin Sales Forecast by Type (2017-2022)
14.9 Europe Recombinant Human Insulin Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Recombinant Human Insulin
Table Classification of Recombinant Human Insulin
Figure Europe Sales Market Share of Recombinant Human Insulin by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Recombinant Human Insulin
Figure Europe Sales Market Share of Recombinant Human Insulin by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure France Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure UK Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure Russia Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure Italy Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure Spain Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure Benelux Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Figure Europe Recombinant Human Insulin Sales and Growth Rate (2012-2022)
Figure Europe Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Table Europe Recombinant Human Insulin Sales of Key Manufacturers (2015 and 2016)
Table Europe Recombinant Human Insulin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Human Insulin Sales Share by Manufacturers
Figure 2016 Recombinant Human Insulin Sales Share by Manufacturers
Table Europe Recombinant Human Insulin Revenue by Manufacturers (2015 and 2016)
Table Europe Recombinant Human Insulin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Recombinant Human Insulin Revenue Share by Manufacturers
Table 2016 Europe Recombinant Human Insulin Revenue Share by Manufacturers
Table Europe Recombinant Human Insulin Sales and Market Share by Type (2012-2017)
Table Europe Recombinant Human Insulin Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Human Insulin by Type (2012-2017)
Figure Europe Recombinant Human Insulin Sales Growth Rate by Type (2012-2017)
Table Europe Recombinant Human Insulin Revenue and Market Share by Type (2012-2017)
Table Europe Recombinant Human Insulin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Human Insulin by Type (2012-2017)
Figure Europe Recombinant Human Insulin Revenue Growth Rate by Type (2012-2017)
Table Europe Recombinant Human Insulin Sales and Market Share by Countries (2012-2017)
Table Europe Recombinant Human Insulin Sales Share by Countries (2012-2017)
Figure Sales Market Share of Recombinant Human Insulin by Countries (2012-2017)
Table Europe Recombinant Human Insulin Revenue and Market Share by Countries (2012-2017)
Table Europe Recombinant Human Insulin Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Recombinant Human Insulin by Countries (2012-2017)
Table Europe Recombinant Human Insulin Sales and Market Share by Application (2012-2017)
Table Europe Recombinant Human Insulin Sales Share by Application (2012-2017)
Figure Sales Market Share of Recombinant Human Insulin by Application (2012-2017)
Figure Germany Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure Germany Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure Germany Recombinant Human Insulin Sales Price Trend (2012-2017)
Table Germany Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)
Table Germany Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)
Table Germany Recombinant Human Insulin Sales by Type (2015 and 2016)
Table Germany Recombinant Human Insulin Market Share by Type (2015 and 2016)
Table Germany Recombinant Human Insulin Sales by Application (2015 and 2016)
Table Germany Recombinant Human Insulin Market Share by Application (2015 and 2016)
Figure France Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure France Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure France Recombinant Human Insulin Sales Price Trend (2012-2017)
Table France Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)
Table France Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)
Table France Recombinant Human Insulin Sales by Type (2015 and 2016)
Table France Recombinant Human Insulin Market Share by Type (2015 and 2016)
Table France Recombinant Human Insulin Sales by Application (2015 and 2016)
Table France Recombinant Human Insulin Market Share by Application (2015 and 2016)
Figure UK Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure UK Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure UK Recombinant Human Insulin Sales Price Trend (2012-2017)
Table UK Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)
Table UK Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)
Table UK Recombinant Human Insulin Sales by Type (2015 and 2016)
Table UK Recombinant Human Insulin Market Share by Type (2015 and 2016)
Table UK Recombinant Human Insulin Sales by Application (2015 and 2016)
Table UK Recombinant Human Insulin Market Share by Application (2015 and 2016)
Figure Russia Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure Russia Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure Russia Recombinant Human Insulin Sales Price Trend (2012-2017)
Table Russia Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)
Table Russia Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)
Table Russia Recombinant Human Insulin Sales by Type (2015 and 2016)
Table Russia Recombinant Human Insulin Market Share by Type (2015 and 2016)
Table Russia Recombinant Human Insulin Sales by Application (2015 and 2016)
Table Russia Recombinant Human Insulin Market Share by Application (2015 and 2016)
Figure Italy Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure Italy Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure Italy Recombinant Human Insulin Sales Price Trend (2012-2017)
Table Italy Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)
Table Italy Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)
Table Italy Recombinant Human Insulin Sales by Type (2015 and 2016)
Table Italy Recombinant Human Insulin Market Share by Type (2015 and 2016)
Table Italy Recombinant Human Insulin Sales by Application (2015 and 2016)
Table Italy Recombinant Human Insulin Market Share by Application (2015 and 2016)
Figure Spain Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure Spain Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure Spain Recombinant Human Insulin Sales Price Trend (2012-2017)
Table Spain Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)
Table Spain Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)
Table Spain Recombinant Human Insulin Sales by Type (2015 and 2016)
Table Spain Recombinant Human Insulin Market Share by Type (2015 and 2016)
Table Spain Recombinant Human Insulin Sales by Application (2015 and 2016)
Table Spain Recombinant Human Insulin Market Share by Application (2015 and 2016)
Figure Benelux Recombinant Human Insulin Sales and Growth Rate (2012-2017)
Figure Benelux Recombinant Human Insulin Revenue and Growth Rate (2012-2017)
Figure Benelux Recombinant Human Insulin Sales Price Trend (2012-2017)
Table Benelux Recombinant Human Insulin Sales by Manufacturers (2015 and 2016)
Table Benelux Recombinant Human Insulin Market Share by Manufacturers (2015 and 2016)
Table Benelux Recombinant Human Insulin Sales by Type (2015 and 2016)
Table Benelux Recombinant Human Insulin Market Share by Type (2015 and 2016)
Table Benelux Recombinant Human Insulin Sales by Application (2015 and 2016)
Table Benelux Recombinant Human Insulin Market Share by Application (2015 and 2016)
Table Recombinant Human Insulin Basic Information List
Table Novo Nordisk Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Recombinant Human Insulin Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Recombinant Human Insulin Sales Market Share (2012-2017)
Table Bioton Basic Information List
Table Bioton Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bioton Recombinant Human Insulin Sales Market Share (2012-2017)
Table Dongbao Basic Information List
Table Dongbao Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Dongbao Recombinant Human Insulin Sales Market Share (2012-2017)
Table United Laboratories (TUL) Basic Information List
Table United Laboratories (TUL) Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Table United Laboratories (TUL) Recombinant Human Insulin Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Insulin
Figure Manufacturing Process Analysis of Recombinant Human Insulin
Figure Recombinant Human Insulin Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Human Insulin Major Manufacturers in 2015
Table Major Buyers of Recombinant Human Insulin
Table Distributors/Traders List
Figure Germany Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)
Figure Germany Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)
Figure France Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)
Figure France Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)
Figure UK Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)
Figure UK Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)
Figure Russia Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)
Figure Italy Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)
Figure Spain Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Recombinant Human Insulin Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)
Table Europe Recombinant Human Insulin Sales Forecast by Type (2017-2022)
Table Europe Recombinant Human Insulin Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *